Literature DB >> 27871834

pH-Sensitive PEGylated liposomes for delivery of an acidic dinitrobenzamide mustard prodrug: Pathways of internalization, cellular trafficking and cytotoxicity to cancer cells.

Mimi M Yang1, William R Wilson2, Zimei Wu3.   

Abstract

This paper aims to develop and evaluate a pH-sensitive PEGylated liposomal (pPSL) system for tumor-targeted intracellular delivery of SN25860, a weakly acidic, poorly water-soluble dinitrobenzamide mustard prodrug which is activated by the E. coli nitroreductase nfB. pPSL and non pH-sensitive liposomes (nPSL), as reference, were formulated by thin-film hydration; an active drug loading method was developed with the aid of solubilizers. Cytotoxicity was evaluated in an nfsB-transfected EMT6 mouse mammary carcinoma cell line. Cellular uptake of liposomes was evaluated by both high performance liquid chromatography and flow cytometry. Intracellular trafficking was visualised by confocal microscopy. High drug loading (7.0±0.2% w/w) was achieved after systematic optimization of drug loading conditions. pPSL-SN25860 demonstrated a 21 and 24- fold increase in antiproliferative potency compared to nPSL-SN25860 and free drug, respectively. Cells treated with pPSL had a 1.6-2.5- fold increase in intracellular drug concentration compared to nPSL. This trend was consistent with flow cytometry results. Cells treated with chlorpromazine demonstrated reduced uptake of both nPSL (40%) and pPSL (46%), indicating clathrin-mediated endocytosis was the major pathway. Confocal microscopy showed that pPSL had not only undergone faster and greater endocytosis than nPSL but was also homogeneously distributed in the cytosol and nuclei suggesting endosome escape, in contrast to nPSL.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (CID 406952); (CID 44134771); (CID 5997); 1,2-Distearoyl-sn-glycero-3-Phosphoethanolamine-N-[Methoxy(Polyethylene glycol)-2000]; 1,2-dioleoy-sn-glycero-3-phosphoethanolamine; 1,2-distearoyl-sn-glycero-3-phosphocholine; Active loading; CHEMS (CID 65082); Cholesterol; Cholesteryl hemisuccinate; DOPE (CID 9546744); DSPC (CID 94190); Endosome escape; Gene-directed enzyme-prodrug therapy; Hydroxypropyl-β-cyclodextrin; pH-sensitive liposomes

Mesh:

Substances:

Year:  2016        PMID: 27871834     DOI: 10.1016/j.ijpharm.2016.11.041

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  PEG-Benzaldehyde-Hydrazone-Lipid Based PEG-Sheddable pH-Sensitive Liposomes: Abilities for Endosomal Escape and Long Circulation.

Authors:  Manju Kanamala; Brian D Palmer; Hamidreza Ghandehari; William R Wilson; Zimei Wu
Journal:  Pharm Res       Date:  2018-05-31       Impact factor: 4.200

Review 2.  Liposomal delivery of CRISPR/Cas9.

Authors:  Shuai Zhen; Xu Li
Journal:  Cancer Gene Ther       Date:  2019-11-02       Impact factor: 5.987

Review 3.  Endosomal Escape of Bioactives Deployed via Nanocarriers: Insights Into the Design of Polymeric Micelles.

Authors:  Adeel Masood Butt; Nabiha Abdullah; Nur Najihah Izzati Mat Rani; Naveed Ahmad; Mohd Cairul Iqbal Mohd Amin
Journal:  Pharm Res       Date:  2022-05-26       Impact factor: 4.200

4.  Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer.

Authors:  Min Woo Kim; Takuro Niidome; Ruda Lee
Journal:  Mar Drugs       Date:  2019-10-12       Impact factor: 5.118

5.  The involvement of extracellular vesicles in the transcytosis of nanoliposomes through brain endothelial cells, and the impact of liposomal pH-sensitivity.

Authors:  Joy N Reginald-Opara; Darren Svirskis; Song Yee Paek; Mingtan Tang; Simon J O'Carroll; Justin M Dean; Lawrence W Chamley; Zimei Wu
Journal:  Mater Today Bio       Date:  2022-02-05

6.  Calcium Enabled Remote Loading of a Weak Acid Into pH-sensitive Liposomes and Augmented Cytosolic Delivery to Cancer Cells via the Proton Sponge Effect.

Authors:  Mimi M Yang; Sasi Bhushan Yarragudi; Stephen M F Jamieson; Mingtan Tang; William R Wilson; Zimei Wu
Journal:  Pharm Res       Date:  2022-02-28       Impact factor: 4.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.